The excitability of the central nervous system depends largely on the surface density of neurotransmitter receptors. The endocannabinoid receptor 1 (CB 1 R) and the metabotropic glutamate receptor mGlu 8 R are expressed pre-synaptically where they reduce glutamate release into the synaptic cleft. Recently, the CB 1 R interacting protein cannabinoid receptor interacting protein 1a (CRIP1a) was identified and characterized to regulate CB 1 R activity in neurons. However, underlying molecular mechanisms are largely unknown. Here, we identified a common mechanism used by CRIP1a to regulate the cell surface density of two different types of Gprotein coupled receptors, CB 1 R and mGlu 8a R. Five amino acids within the CB 1 R C-terminus were required and sufficient to reduce constitutive CB 1 R endocytosis by about 72% in the presence of CRIP1a. Interestingly, a similar sequence is present in mGlu 8a R and consistently, endocytosis of mGlu 8a R depended on CRIP1a, as well. Docking analysis and molecular dynamics simulations identified a conserved serine in CB 1 R (S468) and mGlu 8a R (S894) that forms a hydrogen bond with the peptide backbone of CRIP1a at position R82. In contrast to mGlu 8a R, the closely related mGlu 8b R splice-variant carries a lysine (K894) at this position, and indeed, mGlu 8b R endocytosis was not affected by CRIP1a. Chimeric constructs between CB 1 R, mGlu 8a R, and mGlu 8b R underline the role of the identified five CRIP1a sensitive amino acids. In summary, we suggest that CRIP1a negatively regulates endocytosis of two different G-protein coupled receptor types, CB 1 R and mGlu 8a R.
Electrical activity in the central nervous system (CNS) is guided by neurotransmitter receptors that are expressed at synaptic specializations. Endocannabinoids regulate the Gprotein coupled receptors (GPCRs) cannabinoid receptor 1 (CB 1 R) and CB 2 R that modulate neuronal activity (Kano et al. 2009) . CB 1 R is responsible for the effects of marijuana and involved in several physiological processes, including motor activity, learning and memory, nociception and vision. CB 1 R is highly expressed in the CNS where it is often found at the pre-synaptic site of glutamatergic synapses (Lu and Mackie 2016) . Release of glutamate from the pre-synapse activates post-synaptically located G-protein coupled metabotropic glutamate receptors (mGluR), for example, mGlu 1 R and mGlu 5 R that regulate the activity of the phospholipase C pathway. Ultimately, this results in the production of lipophilic 2-arachidonoyl glycerol molecules that diffuse retrogradely through the synaptic cleft where they activate pre-synaptic CB 1 R, thereby reducing the initial glutamate release (Kano 2014) .
Besides activating mGlu 1 R and mGlu 5 R at the postsynapse, pre-synaptically secreted glutamate also binds to glutamate receptors at the presynapse, for example, mGlu 8 R that function as auto-receptor (Ferraguti and Shigemoto 2006) . Thus, CB 1 R and mGlu 8 R both are part of negative feedback loops that regulate and limit the glutamate concentration in the synaptic cleft, as demonstrated, for example, in photoreceptors of the mammalian retina (Koulen et al. 1999; Fan and Yazulla 2007) . Indeed, a functional relationship between CB 1 R and mGluR types was already suggested (Doherty and Dingledine 2003) .
Recently, the cannabinoid receptor interacting protein 1 (CRIP1) was identified as a binding partner of the intracellular CB 1 R C-terminal domain (Niehaus et al. 2007 ). The CRIP1 gene product is alternatively spliced, resulting in the Cterminal isoforms CRIP1a and CRIP1b. CRIP1a is highly expressed in the brain, where it is co-localized with CB 1 R in pre-synaptic compartments of excitatory glutamatergic and inhibitory GABAergic neurons (Guggenhuber et al. 2016) . Several groups showed that CRIP1a modulates CB 1 R signaling in neuronal cell lines and hippocampal cells Smith et al. 2015; Guggenhuber et al. 2016) . However, underlying molecular mechanisms were not analyzed in detail. As for most GPCR types, the efficacy of CB 1 R signaling also strongly depends on the receptors 0 surface density, which in turn is guided by its intracellular C-terminal domain. Indeed, mutation of serine/threonine residues representing potential phosphorylation sites in the distal CB 1 R Cterminus reduced receptor endocytosis (Daigle et al. 2008 ).
Given the above described similarities in structure, expression, and function between CB 1 R and mGlu 8 R, we hypothesized that both GPCRs might be regulated by CRIP1a. Using a previously established internalization assay (Linck et al. 2015) in combination with bioinformatic techniques, here we present data that constitutive endocytosis of two GPCRs, CB 1 R and mGlu 8a R is negatively regulated by CRIP1a by a common mechanism. Our findings are supported by recent data that describe a competition between CRIP1a and barrestin for the CB 1 R C-terminus (Blume et al. 2016b) . In summary, we propose that CRIP1a functions as a regulator of two different GPCR types, CB 1 R and mGlu 8a R.
Materials and methods
Experiments were carried out in accordance with the guidelines of the University Erlangen-N€ urnberg and the Deutsche Forschungsgemeinschaft.
Molecular biology
The coding sequence of CRIP1a, protein interacting with C-kinase 1 (PICK1) and CB 1 R were amplified from a brain cDNA library by PCR and inserted in the expression vector pRK7. GST (Glutathione S-transferase) was present in pBK/RSV. Coding sequences of mGlu 6 R (kindly provided by J.-P. Pin, Institut de G enomique Fonctionnelle, Montpellier, France), mGlu 8a R and mGlu 8b R (kindly provided by F. Ferraguti, Dept. Pharmacology, Innsbruck, Austria) were present in pRK7 or pcDNA3.1. Deletion and mutant constructs of CRIP1a, CB 1 R and mGlu 8a R, as well as CRIP1a-GFP and mGlu 8a R-DsRed were generated using standard PCR cloning techniques. For pull-down assays, CRIP1a was tagged with Nterminal His-and T7-tags by cloning into pET21, while CB 1 R and mGlu 8a R C-termini were fused to GST in pET41 (Novagen, Madison, WI, USA). Proteins were expressed in E. coli BL21 (DE3)pLysS and lysed in a French press (Thermo Electron Corporation, Needham Heights, MA, USA). Glutathione Sepharose (Novagen) was coated with GST and GST fusion proteins and incubated with CRIP1a that was purified by Ni 2+ -affinity and desalted using a Sephadex G-25 column (GE Healthcare, Freiburg, Germany), following the manufacturer's protocol. Bound CRIP1a was detected by western blotting using a monoclonal anti-T7 immuneserum as described (Rose et al. 2008) .
Cell culture and immunocytochemistry
Human embryonic kidney (HEK293, ATCC â CRL-1573 TM ; CVCL_0045) cells were cultivated and transfected in minimum essential media (21090-022 -without glutamate and aspartate; ThermoFisher, Bonn, Germany) as described (Linck et al. 2015) . In all experiments, 0.5 lg of receptor DNA was mixed with 1.5 lg of CRIP1a, PICK1 or GST encoding plasmids, except for Fig. 1(d) . Successful expression of CB 1 R, mGlu 6 R, mGlu 8a R and mGlu 8b R was evident from the internalization assay. Successful expression of co-transfected plasmids encoding CRIP1a or PICK1 was monitored in separate experiments, as follows: Cells were transfected with plasmid combinations specified in Figs 2-5, fixed and blocked for antibody staining as described (Rose et al. 2008) . The primary antibodies used were CRIP1a (rabbit 1 : 300; SAB3501038; Sigma, St Louis, MO, USA) or PICK1 (goat 1 : 100; sc-9539; RRID: AB_2164539; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After washing, secondary antibodies coupled to Cy3 (goat antirabbit; 1 : 500; RRID:AB_2338006; Jackson Immuno-Research, West Grove, PA, USA) or Alexa TM 488 (chicken anti-goat; 1 : 500; RRID:AB_141893; Life Technologies, Grand Island, NY, USA) were applied to label the primary antibodies.
Cultures of cortical neurons were prepared from E18 SpragueDawley rats in Hank's balanced salt solution as previously described (Valenzuela et al. 2014) . In brief, the cortex (excluding olfactory bulb and hippocampus) was dissected, washed in Hank's balanced salt solution , -Mg 2+ ) and incubated in Hank's balanced salt solution containing trypsin for 5 min (37°C). After trypsin removal cells were carefully dispersed in Dulbecco's modified Eagle's medium containing 10% fetal calf serum. Cells were plated at a density of 100 9 10 3 cells per mL on poly-lysine pre-coated cover slips in a 24-well plate.
Cultures were maintained in serum-free neurobasal medium (Invitrogen, Carlsbad, CA, USA) containing GS21 supplement (Sigma) and kept at 37°C in 5% CO 2 . After 8 days in culture, cells were cotransfected with expression plasmids encoding for CRIP1a-GFP and mGlu 8a R-DsRed, using 0.4 lg of each plasmid DNA, 40 lL effectene and 6.4 lL enhancer in 60 lL EC-Buffer (all from Qiagen, Hilden, Germany) plus 190 lL neurobasal medium per well. After 3 days, cells were washed, fixed in 4% formaldehyde/phosphatebuffered saline for 10 min on ice and mounted with Aqua Poly/Mount (Polysciences Inc., Warrington, PA, USA). Fluorescent signals were examined as described in the next paragraph and contrast enhanced for better visualization (Adobe Photoshop CS5; Adobe Systems Inc., San Jose, CA, USA). Fluorescence profiles were measured with the 'Plot Profile' tool of ImageJ (U. S. National Institutes of Health, Bethesda, Maryland, USA) (version 1.49g).
Internalization assay
The internalization assay was performed as described (Linck et al. 2015) (Fig. 1a) . In brief, antibodies recognizing extracellular epitopes in the N-termini of CB 1 R, mGlu 6 R, mGlu 8a R and mGlu 8b R detected receptors present at the cell surface in unfixed cells under serum-free and non-permeabilizing conditions on ice: CB 1 R (rabbit 1 : 150; C1233; RRID:AB_477655; Sigma), mGlu 6 R (rabbit 1 : 100; PAB26500; Abnova, Paderborn, Germany), mGlu 8a/b R (rabbit 1 : 150; G2045; RRID:AB_477001; Sigma). Specificity of the immune sera was tested in Figure S1 . Binding of primary antibodies was visualized by secondary antibodies coupled to red fluorescence (goat anti-rabbit Cy3; 1 : 200; Jackson ImmunoResearch Laboratories). Thereafter, antibody-labeled receptors were allowed to endocytose at 37°C for 0-90 min. Cells were placed on ice to stop endocytosis and incubated under non-permeabilizing conditions for 1 h with a second secondary antibody (chicken antigoat Alexa TM 488; 1 : 100; Life Technologies). GPCRs present in the plasma membrane were detected in yellow, while internalized receptors appeared as red dots (Fig. 1b) . Endocytosis between cells were compared as previously (Linck et al. 2015) . Each plasmid combination was transfected and analyzed in at least three independent experiments, except for control experiments described in the next paragraph. For each transfection, multiple optical sections were recorded (Table S1 ) with identical microscope settings using a Zeiss Axio Imager Z1 equipped with an ApoTome, a 639 oil objective (Plan-Apochromat 639/1.40 oil DIC M27) and a AxioCam MR3 ccd camera at a resolution of 1388 9 1042 pixel in the 1 9 1 binning mode under control of the AxioVision 4.6.3 software (Zeiss, Oberkochen, Germany). In a previous study analyzing endocytosis of GABAc receptors (Linck et al. 2015) , we performed extensive control experiments to validate the newly established technique, analyzing, for example, the incubation time of HEK293 cells at 37°C to allow receptor endocytosis, the amount of transfected plasmid and amount and nature of antibodies. Here we used different receptor types and antibodies and thus tested again how incubation time and amount of transfected DNA would influence receptor internalization. Based on the results shown in Figs 1(c,d) and 4(c), for all internalization assays throughout this study we used an incubation time of 45 min at 37°C for receptor endocytosis, and transfected 0.5 lg receptor DNA plus 1.5 lg DNA for cytosolic proteins (CRIP1a, PICK1 or GST). Furthermore, we took advantage of the constitutive endocytosis observed at 45 min of the three GPCR types analyzed (CB 1 R-27.6%, mGlu 8a R-28.4%, mGlu 8b R-16.2%, Table S1 ) that allowed us to detect positive, as well as potential negative effects of co-expressed proteins on receptor internalization.
Statistics
Microcal Origin 9.0 Software (Microcal Software, Northhamton, MA, USA) was used for analysis, calculation of statistical significance (one-way ANOVA test) and presentation of data. Data are expressed as mean AE SEM.
Bioinformatic techniques
Based on our previous modeling study for the C-terminal nine amino acids of the CB 1 R C-terminus (S464-TDTSAEA-L472) in contact with CRIP1a (Ahmed et al. 2014) , we carried out modeling studies for the corresponding sequences of mGlu 8a R (E890-TNTSSTK-T898) and mGlu 8b R (E890-TNSKSSV-D898). PEP- Table S1 ). (c) CB 1 R was co-expressed with CRIP1a lacking N-or C-terminal protein regions, which resulted in a significant reduction of the endogenous CB 1 R endocytosis. Error bars are AE SEM in (b and c), ***p < 0.001. (d) Control stainings of CRIP1a, PICK1 and CRIP1a deletion constructs co-expressed with the GPCRs specified in parentheses, using the same transfection conditions as above. The scale bar is 10 lm.
FOLD, a de novo approach for prediction of peptide structures from amino acid sequences, was used to build the 3D structure (Beaufays et al. 2012) . The structure of the CB 1 R C-terminal nine amino acids was used from our previous molecular modeling study (Ahmed et al. 2014) . Protein-protein docking was performed using the High Ambiguity Driven DOCKing algorithm (Dominguez et al. 2003; van Zundert et al. 2016) . The published homology model of CRIP1a was used for docking of the mGlu 8a R and mGlu 8b R Cterminal sequences as described (Ahmed et al. 2014) . Docked poses were scored using the HINT forcefield (Eugene Kellogg and Abraham 2000) .
The 3D models of mGlu 8a R-CRIP1a and mGlu 8b R-CRIP1a complexes were further refined by subjecting them to an all-atom molecular dynamics (MD) simulation. Simulations were carried out with the NAMD 2.9 package developed by the Theoretical and Computational Biophysics Group in the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign (Phillips et al. 2005) . CHARMM (Charmm-27) was used as the force field (MacKerell et al. 1998) . Acetylated Ntermini and methylamidated C-termini were used for mGlu 8a R and mGlu 8b R sequences to simulate their attachment to the rest of their respective proteins. Standard N-and C-termini were used for the GST (black bars) or CRIP1a (gray bars) was co-expressed with different CB 1 R constructs lacking C-terminal regions (Del1 to Del5) and receptor internalization was analyzed. In contrast to wildtype (WT) CB 1 R, the internalization of all CB 1 R deletion constructs was not significantly different in the presence of CRIP1a, except for Del1. The nine amino acids identified by (Niehaus et al. 2007 ) for CRIP1a binding are underlined. (c) The C-terminal 11 amino acids of CB 1 R were independently mutated into an alanine or glycine, as indicated, and their sensitivity for CRIP1a was compared. While most CB 1 R constructs maintained the significant reduction in receptor endocytosis upon coexpressing CRIP1a (gray bars), mutation of five residues resulted in a nearly complete loss of the CRIP1a effect. Successful expression of CRIP1a together with all CB 1 R deletions and alanine mutations analyzed was ensured in separate stainings, as described in Fig. 2 (d) (data not shown). Error bars are AE SEM, *p < 0.05, ***p < 0.001.
CRIP1a protein. The initial MD setup was done using the MDWeb's 'NAMD F3ULL MD Setup' workflow (Hospital et al. 2012) . The 3D models of the mGlu 8a R-CRIP1a and mGlu 8b R-CRIP1a complexes were first solvated in an equilibrated TIP3P water box of dimension 91.8 9 81.8 9 73.8 A using the center of mass of the complex as the origin. Then Cl À and Na + ions were added to neutralize the system and appropriate amount of ions were added up to a concentration of 50 mM. Solvent molecules were first minimized for 500 steps of conjugate gradients minimization method, keeping the protein molecules fixed to allow favorable distribution of water molecules on the complex surface. Subsequently, the system was coupled to a heat bath from 0 to 300 K and the constraints applied to the solute atoms were gradually decreased after which, the system was allowed to be simulated without restraints for over a period of 10 ps. Finally, a 10 ns molecular dynamics production phase was carried out on the entire systems. The analysis of the MD trajectory was done in Visual Molecular Dynamics (Humphrey et al. 1996) . All figures were generated by PyMOL (The PyMOL Molecular Graphics System, Version 1.2r3pre. Schr€ odinger, LLC, Cambridge, MA, USA).
Results

CRIP1a regulates CB 1 R endocytosis
The CB 1 R C-terminus is an important domain for the regulation of receptor endocytosis (Daigle et al. 2008) , which can be inhibited by CRIP1a in the N18TG2 cell line (Blume et al. 2016a,b) . To analyze in detail underlying molecular mechanisms using a previously established internalization assay in HEK293 cells (Fig. 1a ) (Linck et al. 2015) , we tested whether this effect would be present under our experimental conditions, as well. Expression of CB 1 R resulted in a constitutive endocytosis of about 30% after 45 min at 37°C, independent of the amount of transfected receptor DNA (Fig. 1b-d , Table S1 ). Co-expression of the complete coding sequence of CRIP1a (amino acids 1-164; Fig. 2a ) reduced endocytosis by 72% to about 9% (Fig. 2b) . This reduction was specific for CRIP1a, since co-expression of CB 1 R with an unrelated cytosolic protein (PICK1, a well- known interactor of the metabotropic glutamate receptor mGlu 7a R; Dev et al. 2000) did not significantly alter CB 1 R internalization. In addition, CRIP1a had no measurable effect on the endocytosis behavior of an unrelated GPCR (mGlu 6 R). Control stainings ensured a successful expression of CRIP1a and PICK1 under the conditions used (Fig. 2d) . From these data we conclude that the observed reduction in constitutive CB 1 R internalization is not a general mechanism of GPCRs expressed in HEK293 cells, but specifically mediated by CRIP1a. Previously, a central region of CRIP1a (amino acids 34-110) was identified to be sufficient for CB 1 R binding (Niehaus et al. 2007) (Fig. 2a) . To test whether this protein region could reduce the CB 1 R internalization shown in Fig. 2(b) , we generated two CRIP1a deletion constructs (Fig. 2a) . We observed that amino acids 34-110 are sufficient to inhibit endogenous CB 1 R endocytosis similar to wildtype CRIP1a (Fig. 2c, Table S1 ). Importantly, both CRIP1a constructs were expressed in our assay (Fig. 2d) . These data indicate that the observed reduction in CB 1 R internalization by CRIP1a is mediated by the same protein region that was shown to be required for CB 1 R interaction.
Five amino acids in CB 1 R mediate CRIP1a sensitivity In addition to defining the CB 1 R binding region in CRIP1a, the very C-terminal nine amino acids in CB 1 R were identified to be sufficient for interacting with CRIP1a (Niehaus et al. 2007 ). However, the importance of individual insensitive (left). The mGlu 8a R chimera containing CB 1 R specific residues, and both mGlu 8b R chimeras containing CB 1 R or mGlu 8a R specific residues were CRIP1a sensitive (right). In contrast, the presence of mGlu 8b R specific amino acids in mGlu 8a R abolished this effect completely (right). Expression of CRIP1a together with the chimeras was monitored in separate stainings, as described in Fig. 2(d) (data not shown). Error bars are AE SEM, ***p < 0.001.
amino acids within this protein region was not further specified. Here, we took advantage of the pronounced effect on CB 1 R internalization by CRIP1a and used our internalization assay to map CRIP1a sensitive amino acids in a cellular context. First, we generated various C-terminal deletion mutants of CB 1 R (Fig. 3a and b) . Surprisingly, the internalization of all constructs analyzed was no longer dependent on CRIP1a, indicating an involvement of the very C-terminal amino acids (Fig. 3b) . Nevertheless, the internalization of all deletion constructs was comparable (between 30% and 35%; Table S1 ), in line with a previous finding that showed that deleting the C-terminal 14 residues had no consequences on CB 1 R internalization (Daigle et al. 2008) .
In a second step, we mutated each of the 11 C-terminal amino acids of CB 1 R into an alanine or a glycine, depending on the nature of the original residue. These experiments identified two regions required for CRIP1a sensitivity that were composed of amino acids D466, T467, S468 and the very C-terminal amino acids A471, L472 (Fig. 3c , Table S1 ). This is consistent with our data from the CB 1 R deletion constructs (Fig. 3b) that showed a dependence of the CRIP1a effect on the very C-terminal amino acids of CB 1 R. Importantly, all CB 1 R constructs tested in Fig. 3 showed constitutive internalization comparable to the wild-type CB 1 R of about 30%, when expressed individually. From these data, we conclude that two linear sequence motifs in the CB 1 R C-terminal domain, represented by amino acids 466-468 (DTS) and by amino acids 471 and 472 (AL) are required to regulate CB 1 R endocytosis by CRIP1a.
CRIP1a regulates mGlu 8a R, but not mGlu 8b R endocytosis Crosstalk between neurotransmitter receptors is a key mechanism to coordinate signal pathways in neurons. Given the coexpression of CB 1 R and mGluR types at pre-synaptic specializations of glutamatergic synapses in several CNS regions, including cerebellum, hippocampus and retina (Koulen et al. 1999; Monory et al. 2006; Yazulla 2008; Guggenhuber et al. 2016) , we next asked the question whether CRIP1a could be involved in regulating mGluR types, as well. To this end, we aligned C-terminal sequences of CB 1 R and mGluR types. Interestingly, we identified a linear amino acid sequence in the C-terminus of mGlu 8a R (amino acids 892-894: NTS; Fig. 4a ) that is highly homologous to the three amino acids identified in Fig. 3c (DTS) , being different only in the first position. We hypothesized that an exchange between asparagine and aspartic acid might be tolerated by CRIP1a, since different species carry homologous residues at the respective CB 1 R position CB 1 R, including an aspartic acid in primates and rodents, an asparagine in cat and a glutamate in fish (see Fig. 4b ). In contrast to mGlu 8a R, the mGlu 8b R C-terminus does not show the same homology to CB 1 R, since it carries al lysine (K894) instead of the conserved serine/threonine at position 894 (Fig. 4a) .
Based on these observations, we tested whether CRIP1a, besides effecting CB 1 R, would also regulate the internalization of the two mGlu 8 R isoforms. First, we monitored the endocytosis behavior of mGlu 8a R and mGlu 8b R over 90 min (Fig. 4c, Table S1 ). Next, we co-expressed mGlu 8a R with CRIP1a, which reduced endocytosis of this glutamate receptor by 35% to about 16% (Fig. 4d, Table S1 ). In contrast, mGlu 8b R was not significantly influenced by CRIP1a. As already observed for CB 1 R, the CRIP1a effect on mGlu 8a R internalization was specific, since co-expression with PICK1 did not alter mGlu 8a R internalization significantly. From these data we conclude that CRIP1a regulates internalization of mGlu 8a R but not of the mGlu 8b R isoform.
To support this isoform specific effect of CRIP1a, we next tested whether the isoform-specific distal region of the mGlu 8a R C-termini was the only receptor region required for CRIP1a sensitivity. To this end, we deleted all amino acids of the C-terminus of mGlu 8a R located distal from the splice site, generating a receptor construct that contained only the proximal C-terminal sequence, being identical between the two mGlu 8 R variants (mGlu 8 RΔ; Fig. 4a ). Our assay showed that internalization of mGlu 8 RΔ was independent of the presence of CRIP1a ( Fig. 4d ; Table S1 ), suggesting that the CRIP1a effect is mediated by amino acids present in the distal isoform-specific region of the mGlu 8a R C-terminus. As before, successful expression of CRIP1a and PICK1 in combination with the mGlu 8 R constructs was controlled by immunocytochemistry (Fig. 4e) .
The mapped five amino acids are required and sufficient for CRIP1a sensitivity of CB 1 R and mGlu 8a R Based on our data we hypothesized that a linear sequence motif containing two groups of amino acids, as indicated by gray bars in Fig. 4(a) , mediate the CRIP1a regulation of receptor endocytosis. To verify this hypothesis, we generated several chimeric receptors, in which the first and the second group of amino acids were tested individually or in combination (Fig. 5a ). As predicted, all receptors containing amino acids of CB 1 R or mGlu 8a R in their C-terminal domains showed CRIP1a sensitive endocytosis (Fig. 5b , Table S1 ). In contrast, introducing mGlu 8b R specific amino acids into CB 1 R or into mGlu 8a R completely abolished this effect. Most importantly, introduction of a single lysine (K894) of mGlu 8b R into the CB 1 R sequence was sufficient to abolish CRIP1a sensitivity of CB 1 R (CB 1 /mGlu 8b R-2 in Fig. 5a and b) . From these data we conclude that the mapped five amino acids are required and sufficient to regulate the endocytosis of CB 1 R and mGlu 8a R by CRIP1a.
CB 1 R and mGlu 8a R show a common conformation in contact with CRIP1a CRIP1 interacted with the intracellular CB 1 R C-terminal domain in a GST pull-down assay (Niehaus et al. 2007 ) and this holds true for the mGlu 8a R C-terminus, as well (Fig. 6a) .
Furthermore, CRIP1a and mGlu 8a R were co-localized in cortical neurons (Fig. 6b) . Therefore, we next compared the conformation of the mapped protein region in the receptors 0 C-termini in contact with CRIP1a ( Fig. 6c and d) . The peptide conformation of CB 1 R and mGlu 8a R were very similar in the generated models, which differ significantly from that of mGlu 8b R (Fig. 6c -right panel) . This conformation difference can be attributed to the bulky mGlu 8b R-K894, which cannot fit properly into CRIP1a's binding site prompting a suboptimal binding conformation compared to CB 1 R-S468 and mGlu 8a R-S894. These data are in agreement with our internalization assay, in which introduction of K894 into the CB 1 R sequence was sufficient to abolish CRIP1a sensitivity of CB 1 R (Fig. 5b) . mGlu 8a R-and mGlu 8b R-CRIP1a docked poses were scored using the HINT force field. HINT, known as a 'natural' force field, describes and quantifies all interactions in the biological environment by exploiting the interaction information implicit in LogP o/w (the partition coefficient for 1-octanol/water solute transfer). Thus, it encodes interaction types including Columbic, hydrogen bond and hydrophobic interactions expected to be found between molecules in the biological environment (Eugene Kellogg and Abraham 2000) . Higher HINT scores indicate favorable binding and vice versa. HINT analysis of the docked model of mGlu 8a RCRIP1a indicated a favorable interaction with a HINT score of 700, which is comparable to the HINT score for the CB 1 RCRIP1a model previously obtained (980) (Ahmed et al. 2014) (Fig. 6e) . On the other hand, the HINT score for the mGlu 8b R-CRIP1a model was À2000, indicating a significantly unfavorable interaction. These data are consistent with the results from our internalization assay, in which CRIP1a reduces constitutive endocytosis of CB 1 R and mGlu 8a R, but not of mGlu 8b R. The scale bar is 10 lm. Docking into CRIP1a (c) was performed with sequences of CB 1 R (cyan), mGlu 8a R (magenta) and mGlu 8b R (yellow) (d). The super imposition shows that the CRIP1a surface (silver) can accommodate the sidechains of CB 1 R-S468 and mGlu 8a R-S894, while the bulky side-chain of mGlu 8b R-K894 appears to cause a significant conformational change in the pose of the mGlu 8b R sequence resulting in an unfavorable binding. (e) This is reflected in the HINT analysis, which showed a significant lower score for mGlu 8b R-CRIP1a (red) compared to that of CB 1 R-CRIP1a and mGlu 8a R-CRIP1a (green). (f) The root mean square deviation (RMSD) of mGlu 8a R and mGlu 8b R peptides throughout the 10 ns Molecular dynamics simulation of their complexes with cannabinoid receptor interacting protein 1a (CRIP1a).
Finally, the mGlu 8a R-CRIP1a and mGlu 8b R-CRIP1a complex models were subjected to molecular dynamics (MD) simulations for further refinement. After equilibration, the root mean square deviation (RMSD), which measures average distances between CRIP1a backbone atoms, was stabilized at < 2.5 A relative to the starting structure indicating that the simulations were reasonably converged. MGlu 8b R was very unstable during the simulation, as evidenced by the erratic changes in RMSD of the peptide relative to its starting conformation during the simulation (Fig. 6f) , and completely dissociated from CRIP1a by the end of the simulation. On the other hand, mGlu 8a R was more stable. Aside from a small readjustment at the first amino acid of the mGlu 8a R peptide (E890) that happened around 5 ns (and did not affect its interaction with CRIP1a in any way) no major changes were observed for the peptides position throughout the simulation. This is made evident by the more stable RMSD of the peptide relative to its starting conformation during the simulation (Fig. 6f) . A comparison of the average root mean square fluctuation (which is a measure of the average atomic mobility) of residues in the same position in CB 1 R, mGlu 8a R and mGlu 8b R shows a significantly higher mobility of mGlu 8b R peptide relative to mGlu 8a R or CB 1 R ( Figure S2) .
The binding mode of the mGlu 8a R sequence after the MD simulation is shown in Fig. 7(a) . Most notably, the model suggests that hydrogen bonds are formed between the mGlu 8a R backbone carbonyl oxygens of E890, T891 and N892 with the K130 0 s terminal amine from CRIP1a (Fig. 7c) . In addition, a hydrogen bond is formed between the mGlu 8a R sidechain of T893 and the phenolic oxygen of Y85 as well as the carbonyl oxygen of the backbone of N61 from CRIP1a. Also, the mGlu 8a R sidechain of S894 forms a hydrogen bond with the carbonyl oxygen of R82 from CRIP1a. The model also shows mGlu 8a R-K897 to interact with CRIP1a-E144 via a salt bridge and to form a hydrogen bond with the backbone of CRIP1a-S141. Finally, mGlu 8a R-T898 is engaged in hydrogen bonding with CRIP1a-K76. Interestingly, the interactions between mGlu 8a R and CRIP1a in the model are similar to the interactions predicted between CB 1 R and CRIP1a, with the exception of mGlu 8a R-K897 (Fig. 7b) (Ahmed et al. 2014) . From these data we conclude that the CRIP1a binds to CB 1 R and mGlu 8a R via a common molecular mechanism.
Discussion
A huge variety of surface receptors regulates electrical activity of the CNS. Work from several groups during the last years convincingly showed that different receptor systems can crosstalk to each other, thus multiplying and coordinating their physiological functions. The molecular basis for this crosstalk can, for example, be formed by proteins interacting with intracellular receptor domains, thereby regulating their localization, turnover and ligand affinity. Importantly, these protein interactions represent new drug targets with characteristics distinct from the pharmacological profiles of the individual receptors.
Here, we analyzed the effect of CRIP1a on the internalization behavior of CB 1 R and mGlu 8a R. Based on our data, we propose a common molecular mechanism for both receptor types. We identified five amino acids in the CB 1 R C-terminus (D466, T467, S468, A471 and L472) that were needed to reduce the endogenous endocytosis of the receptor by CRIP1a by about 72%. The predictions resulting from the MD simulation of CB 1 R and mGlu 8a R in contact with CRIP1a are consistent with the receptor mutants tested: All five amino acids of CB 1 R (D466, T467, S468, A471, L472) and of mGlu 8a R (N892, T893, S894, K897, T898) identified in the alanine-scan contact CRIP1a using their side-chain atoms. We propose that mutation of these residues into alanines/glycines disrupted the interactions which prevented the inhibitory effect of CRIP1a on receptor endocytosis. Moreover, the CRIP1a insensitive mGlu 8b R carries a lysine at position 894 (K894) that is not compatible with our model. This is consistent with our finding that endocytosis of chimeric CB 1 R and mGlu 8a R that contain the mGlu 8b R specific K894 at the respective amino acid positions was not inhibited any more by CRIP1a, indicating a disruption of protein interactions. Most interestingly, the CRIP1a insensitive mGlu 8b R was turned into a CRIP1 sensitive receptor by introducing the five corresponding amino acids of CB 1 R or mGlu 8a R. The last two of these five amino acid positions allow some flexibility, since they tolerate different residues in CB 1 R (A471 and L472) and mGlu 8a R (K897 and T898), but not the amino acid pair present in mGlu 8b R (V897 and D898). Thus, we propose that the five amino acids described are essential to bind CRIP1a. The MD simulations showed additional contact sites of CRIP1a with CB 1 R and mGlu 8a R, suggesting that other residues (e.g., K124, K130, S141 and E144) of CRIP1a might contribute to the protein interactions, possibly to increase binding specificity and/or affinity. This idea is supported by our observation that deleting these additional amino acids specified above in the constructs CRIP1a 1-110 and CRIP1a 34-110 resulted in a slightly weaker effect on CB 1 R endocytosis compared to the wildtype. However, since the two CRIP1a deletion constructs are artificial proteins that might fold in an unpredictable manner, we cannot exclude that their effect on CB 1 R endocytosis follows a completely different mechanism.
Consistent with our data, CB 1 R activity was increased upon CRIP1a over-expression In the hippocampus by more than 40% (Guggenhuber et al. 2016) . Interestingly, the Cterminus of mGlu 8a R carries a homologous sequence and indeed, this glutamate receptor was CRIP1a sensitive, as well. Thus, we propose a common mechanism in the regulation of CB 1 R and mGlu 8a R by CRIP1a. Our hypothesis is supported by a co-expression of CB 1 R and CRIP1a in pre-synaptic compartments in the CNS (Guggenhuber et al. 2016) . Co-localization of both proteins has been described in detail in pre-synaptic terminals of photoreceptors of the retina, that in addition to CB 1 R and CRIP1 express mGlu 8 R (Koulen and Brandst€ atter 2002; Hu et al. 2010) . Consistently, we observed a co-localization between mGlu 8a R and CRIP1a in cortical neurons. Previously, it was shown that CRIP1a plays a role in CB 1 R mediated neuroprotective effects at glutamatergic synapses of cortical cells (Stauffer et al. 2011) . Here, we suggest that CRIP1 regulates activity of glutamatergic synapses not only via CB 1 R, but may also directly influence the efficacy of glutamate receptors, namely mGlu 8a R. Indeed, activation of both receptor systems limited the glutamate secretion from the photoreceptor pre-synapse, suggesting a synergistic physiological function (Koulen et al. 1999; Fan and Yazulla 2007) . In this context it is interesting that functional interactions between CB 1 R and the mGluR types 1, 2 and 5 were reported (Palazzos et al. 2006) .
Literature data describing molecular mechanisms of mGlu 8 R endocytosis is rare. One study describes an agonist induced receptor internalization in the enteric nervous system of about 40% (Tong and Kirchgessner 2003) . At glutamatergic synapses of the hippocampus, mGlu 8a R signaling is inhibited by phosphorylation at S855, a serine located in the proximal region of the C-terminal domain; however, underlying molecular mechanisms, for example, receptor endocytosis, were not analyzed (Cai et al. 2001) . Constitutive endocytosis was observed for the closely related mGlu 7 R in HeLa cells and hippocampal neurons (Lavezzari and Roche 2007) . In contrast to mGlu 8 R, several molecular determinants responsible for CB 1 R endocytosis were published.
Several studies analyzed agonist induced endocytosis of CB 1 R (Rozenfeld 2011) . A mutation (D164N) in the second transmembrane domain of CB 1 R prevented receptor internalization . Phosphorylation of two serine residues in the proximal region of the CB 1 R C-terminus (S426, S430) increased receptor desensitization, while receptor internalization was not affected (Jin et al. 1999) . A deletion of the C-terminal 10 amino acids of CB 1 R had no effect on receptor internalization upon agonist binding in AtT-20 cells, while a deletion of the C-terminal 14 amino acids prevented receptor internalization, indicating an importance of residues 460-463 . However, a more recent study using HEK293 cells showed that deletion of the C-terminal 14 amino acids had no effect on CB 1 R internalization (Daigle et al. 2008) . The authors also analyzed the role of individual amino acids for receptor internalization using alanine mutations of serine and threonine residues in different combinations. Double mutations of T461 and S463, S465 and T466, or T468 and S469 had no effect, consistent with our data that showed comparable CB 1 R endocytosis upon individually mutating each of the 11 C-terminal residues. However, exchanging groups of 4 (T461, S463, S465, T466) or all six amino acids by alanine reduced CB 1 R internalization significantly (Daigle et al. 2008) . In contrast to the above discussed findings on agonist induced CB 1 R internalization, we analyzed constitutive receptor endocytosis and found that only T468 and S469 are CRIP1a sensitive. This suggests that CB 1 R is constitutively internalized using T461, S463, S465, T466, T468, S469, while in the presence of CRIP1a the distal 2 hydroxylgroups (T468, S469) are not accessible any more for serine/ threonine kinases, resulting in a reduction of receptor internalization, as observed in the present study.
It was suggested that agonist induced and constitutive endocytose might follow different mechanisms, since they depend on two different b-arrestin proteins (Gyombolai et al. 2013; Blume et al. 2016b) . If these differences include other proteins as well, such as CRIP1a, is currently under discussion. While one group reported CRIP1a to enhance CB 1 R activity in hippocampal cells (Guggenhuber et al. 2016) , others found that constitutive and agonist induced CB 1 R activity was reduced in hippocampal and superior cervical ganglion neurons, N18TG2 and HEK293 cells (Niehaus et al. 2007; Smith et al. 2015) . The latter study compared CB 1 R activity between cell lines that do (N18TG2) or do not (HEK293) natively express CRIP1a. While the authors reported no difference in the regulation of CB 1 R activity, the ratio of CB 1 R/CRIP1a expression was higher in HEK293 cells. A recent review suggests that CRIP1a might have different effects on different G-protein types (Solymosi and Kofalvi 2016) . Thus, in N18TG2 cells CRIP1a negatively influenced the activity of Ga i3 and Ga o but had positive effects on Ga i1/2 . Two amino acids identified by our alanine-scan (T468 and S469) also regulate agonist induced CB 1 R internalization (Daigle et al. 2008) , suggesting that CRIP1a is involved in both, agonist induced and constitutive endocytose mechanisms.
Phosphorylation of GPCR C-termini has been shown to regulate receptor internalization and desensitization, including the C-termini of CB 1 R and mGlu 8a R (Cai et al. 2001; Straiker et al. 2012) . Indeed, mutation of serine/threonine residues located within the distal 14 amino acids of the CB 1 R C-terminus significantly reduced agonist induced receptor endocytosis, as discussed above (Daigle et al. 2008) . However, truncation of the C-terminal 14 (Daigle et al. 2008) or 19 (this study) amino acids did not prevent agonist driven or constitutive CB 1 R internalization. To resolve this discrepancy, it was hypothesized that the unphosphorylated CB 1 R C-terminus functions as an inhibitor of CB 1 R endocytosis (Daigle et al. 2008) . Based on our data, we suggest a molecular mechanism for this hypothesis, in which the inhibitory effect is mediated by an association of the CB 1 R C-terminus with CRIP1a. This suggestion is consistent with our observation that both a deletion of the distal 19 amino acids, as well as mutation of five individual residues in the CB 1 R C-terminus do not change endogenous receptor internalization per se when compared to the wild-type receptor. Furthermore, our suggestion is supported by recent publications showing an inhibitory effect of CRIP1a on CB 1 R internalization in N18TG2 cells, and a reduced CRIP1a binding upon phosphorylation of CB 1 R-T468 (Blume et al. 2016a,b) .
Cell lines are a prominent tool for studying constitutive receptor endocytosis. Indeed, constitutive CB 1 R internalization was analyzed in several non-neuronal and neuronal cell lines, see for example previous discussion or (Grimsey et al. 2010; Gyombolai et al. 2013) . Importantly, constitutive CB 1 R endocytosis is also present in neurons, for example, in the hippocampus (Leterrier et al. 2006; McDonald et al. 2007; Turu et al. 2007; Rozenfeld and Devi 2008) . The constitutive endocytosis of GPCR observed in this study might by due to and influenced by several factors, including a continuous membrane turnover of cells, the amount of surface receptors expressed, or the presence of extracellular molecules, for example, serum components or bivalent antibodies, most of them being controlled in our internalization assay. To avoid that serum components might activate signal cascades that lead to endocytosis, we omitted fetal calf serum from the incubation medium 16 h before the internalization assay started. Consistent with previous data (Linck et al. 2015) , we found that endocytosis was independent from the amount of transfected receptor encoding plasmids.
In the above cited study, we used monovalent Fab fragments as secondary antibodies to eliminate the known clustering effect of bivalent antibodies. Indeed, this reduced the constitutive endocytosis of GABAc receptors from over 50% to about 30%. Since the GPCR types used in this study already showed constitutive internalization of about 30% or less using bivalent secondary antibodies, there was no need to exchange them with monovalent Fab fragments. Rather, we took advantage of these 30% that allowed us to monitor positive, as well as negative changes in receptor endocytosis.
Each combination of plasmids listed in Table S1 was analyzed in at least three independent experiments (except for controls), representing a total of 21-69 optical sections. For most plasmid combinations about 30 optical sections were evaluated, each containing between three and ten cells, resulting in 90-300 cells analyzed. We tested 68 different plasmid combinations, yielding a total of 6100-20 000 cells analyzed. All data points representing one plasmid combination were compared by scatter plots that showed a high reproducibility between the multiple optical sections analyzed. This high reproducibility of the internalization assay is in agreement with the fact that all 23 CB 1 R constructs tested in this study showed a comparable endocytosis of about 30% in the absence of CRIP1a. Furthermore, the internalization behavior of the CB 1 R deletions, the alanine/glycine mutants and the CB 1 R/mGlu 8 R chimeras was not only qualitatively consistent, but quantification showed similar internalization values, too.
Some reports showed that CRIP1a reduced constitutive and agonist induced CB 1 R activity in N18TG2 cells, as well as in hippocampal and superior cervical ganglion neurons (Niehaus et al. 2007; Smith et al. 2015) . Others describe instead that CRIP1a inhibited CB 1 R endocytosis in a neuronal cell line (Blume et al. 2016a,b) and enhanced agonist-induced CB 1 R signaling in pyramidal neurons of hippocampal slice preparations (Guggenhuber et al. 2016) , consistent with our observation that CRIP1a inhibits CB 1 R endocytosis. Because we identified five amino acids responsible for CRIP1a sensitivity that are conserved between CB 1 R and mGlu 8a R, we speculate that CRIP1a has a similar function on both GPCR types. Based on our data, we suggest that CRIP1a represents a negative regulator of CB 1 R and mGlu 8a R endocytosis by reducing receptor internalization from the cell surface, or alternatively by enhancing the recycling of already endocytosed receptors. In both scenarios, serine/threonine phosphorylation in the CB 1 R C-terminus would prevent CRIP1a association and thus maintain the normal constitutive CB 1 R turnover observed in cell lines or hippocampal neurons. While several groups reported recycling of internalized CB 1 R to the plasma membrane, others observed receptor degradation (Rozenfeld 2011) . Thus, both of the suggested mechanisms, a reduction in GPCR internalization or an enhancement of recycling, could explain the observed negative regulation of receptor endocytosis by CRIP1a. CB 1 R and CRIP1a are co-expressed in pre-synaptic compartments of excitatory glutamatergic, and inhibitory GABAergic neurons in various brain regions, including cerebellum and hippocampus (Smith et al. 2015; Guggenhuber et al. 2016) . Interestingly, dentate gyrus cells do not contain CB 1 R, but express CRIP1a (Monory et al. 2006; Guggenhuber et al. 2016) . This suggests that CRIP1a might regulate other GPCRs than CB 1 R, an idea already proposed by others as well . Here, we identified a CRIP1a sensitivity of mGlu 8a R, and both proteins are coexpressed in dentate gyrus cells (Shigemoto et al. 1997; Guggenhuber et al. 2016) . Furthermore, we show a colocalization of CRIP1a and mGlu 8a R in cortical neurons. This offers the possibility that CRIP1a might regulate endocytosis of mGlu 8a R, rather than CB 1 R in this cell type. In summary, we present evidence for a common regulation of endocannabinoid and glutamate receptor systems by CRIP1a.
Acknowledgments and conflict of interest disclosure
We thank Francesco Ferraguti and Jean-Philippe Pin for providing mGluR cDNA sequences, and Renato Frischknecht for neuronal cultures. This work was supported by the Deutsche Forschungsgemeinschaft (EN349/8-1). The authors declare no conflict of interest.
All experiments were conducted in compliance with the ARRIVE guidelines.
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 . CB 1 R, mGlu 8a R or mGlu 6 R transfected (upper panels) or un-transfected (lower panels) HEK293 were stained with immunesera recognizing CB 1 R (left panels), mGlu 8a R (middle panels) or mGlu 6 R (right panels), as described in the methods for the internalization assay. Figure S2 . Comparison of the average RMSF (root mean square fluctuation, which is a measure of the average atomic mobility) of residues in the same position in CB 1 R, mGlu 8a R and mGlu 8b R during the MD simulation (*p < 0.05). Table S1 . Overview of experimental conditions and results of the internalization assays.
